Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ANNX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
41 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 19 days ago
Red flags: 0
217 filers reported a long position in ANNX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $111.5M | 19.5M | +83.5% |
| BlackRock, Inc. | $77.3M | 13.5M | +23.8% |
| Redmile Group, LLC | $67.8M | 11.9M | -18.4% |
| STATE STREET CORP | $56.1M | 9.8M | +42% |
| BVF INC/IL | $49.7M | 8.7M | Unchanged |
| Woodline Partners LP | $39.5M | 6.9M | +196.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | $39.2M | 6.9M | +15.4% |
| MAK CAPITAL ONE LLC | $33.5M | 5.9M | +24.1% |
| GOLDMAN SACHS GROUP INC | $33.3M | 5.8M | +170.6% |
| Siren, L.L.C. | $25.5M | 4.5M | +12.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.